Search results

• Active

  deltaT Y4Q1: Multimodal spatial data analysis for clinically actionable targets in TNBC

  Parsons, M. (Primary Investigator), Grigoriadis, A. (Co-Investigator) & Irshad, S. (Co-Investigator)

  Wellcome Leap Inc.

  1/10/2024 → 31/12/2024

  Project: Research

• Multimodal, multiscale functional tissue state imaging

  Parsons, M. (Primary Investigator), Bergholt, M. (Co-Investigator), Grigoriadis, A. (Co-Investigator) & Sinkus, R. (Co-Investigator)

  Wellcome Trust

  1/10/2024 → 31/03/2026

  Project: Research

• CHAI: CHAI - EPSRC AI Hub for Causality in Healthcare AI with Real Data

  Chockler, H. (Primary Investigator), Grigoriadis, A. (Co-Investigator) & He, Y. (Co-Investigator)

  EPSRC Engineering and Physical Sciences Research Council

  1/02/2024 → 31/01/2029

  Project: Research

• NIHR Pre-doctoral Fellowship Round 5 Holly R.

  Grigoriadis, A. (Primary Investigator)

  NIHR National Institute For Health & Care Research

  1/09/2023 → 28/02/2026

  Project: Research

• Crosstalk Between Tumour and Draining Lymph Nodes and its Impact on Triple-negative Breast Cancer

  Grigoriadis, A. (Primary Investigator) & Karagiannis, S. (Co-Investigator)

  MRC Medical Research Council

  1/12/2022 → 30/11/2025

  Project: Research

• CoL: CRUK City of London Centre renewal (COLMC)

  Ng, T. (Primary Investigator), Arnold, J. (Co-Investigator), Blower, P. (Co-Investigator), Ciccarelli, F. (Co-Investigator), Dazzi, F. (Co-Investigator), Farzaneh, F. (Co-Investigator), Grigoriadis, A. (Co-Investigator), Hayday, A. (Co-Investigator), Irshad, S. (Co-Investigator), Kong, A. (Co-Investigator), Kordasti, S. (Co-Investigator), Lawrence, T. (Co-Investigator), Mishto, M. (Co-Investigator), Papa, S. (Co-Investigator), Purushotham, A. (Co-Investigator), Quek, L. (Co-Investigator), Ramsay, A. (Co-Investigator), Reis Ferreira, M. (Co-Investigator), Sarker, D. (Co-Investigator), Sinkus, R. (Co-Investigator), Spicer, J. (Co-Investigator) & Witney, T. (Co-Investigator)

  CRUK Cancer Research UK

  1/04/2022 → 31/03/2027

  Project: Research

• Integrated multi-modal tissue state mapping of TNBC progression

  Parsons, M. (Primary Investigator), Abbate, V. (Co-Investigator), Ameer-Beg, S. (Co-Investigator), Barber, P. (Co-Investigator), Bergholt, M. (Co-Investigator), Chan, A. (Co-Investigator), Chiappini, C. (Co-Investigator), Cox, S. (Co-Investigator), Gillett, C. (Co-Investigator), Grigoriadis, A. (Co-Investigator), Irshad, S. (Co-Investigator), Karimi, M. M. (Co-Investigator), Ng, T. (Co-Investigator), Ourselin, S. (Co-Investigator), Pinder, S. (Co-Investigator), Purushotham, A. (Co-Investigator), Sinkus, R. (Co-Investigator), Spencer, J. (Co-Investigator) & Stewart, T. (Co-Investigator)

  Wellcome Leap Inc.

  30/09/2021 → 30/09/2025

  Project: Research

• Prognostic value and functional role of germinal centers in lymph nodes of immunotherapy treated breast cancers

  Grigoriadis, A. (Primary Investigator)

  CRUK Cancer Research UK

  27/09/2021 → 26/09/2025

  Project: Research

• Arming the immune response against triple negative breast cancers: Are NKG2D and IL 15 Brothers in Arms?

  Tutt, A. (Primary Investigator), Grigoriadis, A. (Co-Investigator), Hayday, A. (Co-Investigator), Ng, T. (Co-Investigator), Pinder, S. (Co-Investigator) & academic, A. (Co-Investigator)

  Butterfield Trust

  1/09/2012 → 31/12/2027

  Project: Research

• Not started

  Origin of tumour infiltrating lymphocytes, tissue-resident or systemic?

  Grigoriadis, A. (Primary Investigator), Gillett, C. (Co-Investigator), Hayday, A. (Co-Investigator), Pinder, S. (Co-Investigator), Tutt, A. (Co-Investigator) & academic, A. (Co-Investigator)

  Project: Research

• Finished

  PALATINATE, a Platform for pAthoLogical diAgnosTics IN A digiTal Environment

  Grigoriadis, A. (Primary Investigator)

  TSB Technology Strategy Board

  11/03/2024 → 31/10/2024

  Project: Research

• Boosting the development of the radiation-induced abscopal effect as a metastatic TNBC treatment – Preclinical evaluation of key parameters.

  Fruhwirth, G. (Primary Investigator), Gillett, C. (Co-Investigator), Grigoriadis, A. (Co-Investigator) & Sawyer, E. (Co-Investigator)

  MRC Medical Research Council

  1/01/2023 → 30/09/2024

  Project: Research

• CosMX Spatial Molecular Imager

  Chiappini, C. (Primary Investigator), Giacca, M. (Co-Investigator), Grigoriadis, A. (Co-Investigator), Lawrence, T. (Co-Investigator), Parsons, M. (Co-Investigator) & Spagnoli, F. (Co-Investigator)

  MRC Medical Research Council

  1/10/2022 → 31/03/2023

  Project: Research

• Bioinformatics, machine learning and statistical modelling in microbial cancer genomics

  Grigoriadis, A. (Primary Investigator) & Shoaie, S. (Co-Investigator)

  NIHR National Institute For Health & Care Research

  1/09/2022 → 29/02/2024

  Project: Research

• Early detection of cancer in germline BRCA1/2 mutation carriers

  Grigoriadis, A. (Primary Investigator), Gillett, C. (Co-Investigator) & Pinder, S. (Co-Investigator)

  CRUK Cancer Research UK

  1/06/2021 → 31/05/2023

  Project: Research

• Capturing risk predictive changes in sentinel lymph nodes using AI-based approaches

  Grigoriadis, A. (Primary Investigator)

  MRC Medical Research Council

  1/06/2021 → 31/03/2023

  Project: Research

• Dissecting radio-resistance in head and neck squamous cell carcinoma, by applying artificial intelligence approaches to digital pathology and molecular profiles, of primary and recurrent tumours following radiotherapy

  Grigoriadis, A. (Primary Investigator), Kong, A. (Co-Investigator), Ourselin, S. (Co-Investigator) & Thavaraj, S. (Co-Investigator)

  CRUK Cancer Research UK

  15/06/2020 → 31/12/2021

  Project: Research

• Predicting treatment response using non-black box machine learning based pathology and radiology image analysis in breast and head-neck cancers

  Grigoriadis, A. (Primary Investigator), Pinder, S. (Co-Investigator), Ng, T. (Co-Investigator), Gillett, C. (Co-Investigator), Loukidis, G. (Co-Investigator) & Thavaraj, S. (Co-Investigator)

  CRUK Cancer Research UK

  1/04/2020 → 1/12/2020

  Project: Research

• Deep Learning to Predict Outcome in Cancer Patients

  Grigoriadis, A. (Primary Investigator)

  Cambridge Cancer Genomics Ltd

  1/10/2018 → 30/09/2022

  Project: Research

• Unravelling the role of the uninvolved lymph node as a prognostic tool in breast cancer progression

  Grigoriadis, A. (Primary Investigator) & Ng, T. (Co-Investigator)

  Breast Cancer Research Trust

  1/10/2017 → 31/12/2020

  Project: Research

  • Breast Cancer 100%
  • Lymph Node 100%
  • Cancer Growth 100%

• NIHR Biomedical Research Centre. Funding for Financial Years 2017/18, 2018/19

  Wolfe, C. (Primary Investigator), Parsons, M. (Primary Investigator), Gould, H. (Primary Investigator), Corrigan, C. (Primary Investigator), Greenough, A. (Primary Investigator), Peakman, M. (Primary Investigator), Vyse, T. (Primary Investigator), Antoniou, M. (Primary Investigator), Oakey, R. (Primary Investigator), McGrath, J. (Primary Investigator), Karagiannis, S. (Primary Investigator), Barker, J. (Primary Investigator), Flohr, C. (Primary Investigator), Tziotzios, C. (Primary Investigator), Whittaker, S. (Primary Investigator), Spector, T. (Primary Investigator), Watt, F. (Primary Investigator), Hayday, A. (Primary Investigator), Spencer, J. (Primary Investigator), Cope, A. (Primary Investigator), Malim, M. (Primary Investigator), Martin Serrano, J. (Primary Investigator), Edgeworth, J. (Primary Investigator), Cason, J. (Primary Investigator), Lord, G. (Primary Investigator), Dorling, A. (Primary Investigator), Sacks, S. (Primary Investigator), Sanchez Fueyo, A. (Primary Investigator), Lombardi, G. (Primary Investigator), Ostermann, M. (Primary Investigator), Shah, A. (Primary Investigator), Marber, M. (Primary Investigator), Mayr, M. (Primary Investigator), Chowienczyk, P. (Primary Investigator), Wells, C. (Primary Investigator), Grigoriadis, A. (Primary Investigator), Sawyer, E. (Primary Investigator), Maher, J. (Primary Investigator), Tribe, R. (Primary Investigator), Ilic, D. (Primary Investigator), Poston, L. (Primary Investigator), Rutherford, M. (Primary Investigator), Gee, T. (Primary Investigator), Blower, P. (Primary Investigator), Edwards, D. (Primary Investigator), Sharpe, P. (Primary Investigator), Streit, A. (Primary Investigator), Naglik, J. (Primary Investigator), Tavassoli, M. (Primary Investigator) & McNaughton, P. (Primary Investigator)

  NIHR National Institute For Health & Care Research

  1/04/2017 → 31/03/2022

  Project: Research

  • Biomedical Research 100%

• Origin of tumour infiltrating lymphocytes, tissue-resident or systemic?

  Grigoriadis, A. (Primary Investigator), Hayday, A. (Co-Investigator) & Tutt, A. (Co-Investigator)

  1/07/2016 → 31/07/2019

  Project: Research

• Tumour-infiltrating B cell repertoire: High through-put sequencing to therapeutic antibodies

  Grigoriadis, A. (Primary Investigator), Dunn-Walters, D. (Co-Investigator), Karagiannis, S. (Co-Investigator) & Tutt, A. (Co-Investigator)

  1/01/2016 → 31/12/2018

  Project: Research

• Cancer prevention and early detection: The emerging role of biomarkers

  Van Hemelrijck, M. (Primary Investigator), Grigoriadis, A. (Co-Investigator) & Wells, C. (Co-Investigator)

  16/11/2015 → 19/11/2015

  Project: Research

• Uncovering new drivers and mechanisms underlying organ-specific metastatic spread in breast cancers

  Grigoriadis, A. (Primary Investigator)

  1/10/2015 → 1/09/2017

  Project: Research

• Determining the origin of tumour infiltrating T lymphocytes in breast cancer

  Grigoriadis, A. (Primary Investigator)

  1/05/2015 → 1/04/2016

  Project: Research

• Genomic Scars to predict upgrading in men on Active Surveillance

  Grigoriadis, A. (Primary Investigator) & Van Hemelrijck, M. (Co-Investigator)

  Prostate Cancer UK

  27/04/2015 → 26/04/2018

  Project: Research

• Mechanisms of Breast Cancer Metastatic Spread

  Parker, P. (Primary Investigator), Grigoriadis, A. (Co-Investigator), Purushotham, A. (Co-Investigator) & Wells, C. (Co-Investigator)

  Royal Society

  1/03/2015 → 28/02/2017

  Project: Research

• Origin of tumour infiltrating lymphocytes, tissue -resident or systemic?

  Grigoriadis, A. (Primary Investigator), Gillett, C. (Co-Investigator), Hayday, A. (Co-Investigator), Tutt, A. (Co-Investigator) & academic, A. (Co-Investigator)

  1/01/2015 → 31/12/2017

  Project: Research

• Control of expression of cavelolin-1 by KDM5B in breast cancer

  Burchell, J. (Primary Investigator), Grigoriadis, A. (Co-Investigator) & Taylor-Papadimitriou, J. (Co-Investigator)

  1/01/2015 → 31/12/2015

  Project: Research

• HORMAD1, a novel player in genomic instability

  Tutt, A. (Primary Investigator) & Grigoriadis, A. (Co-Investigator)

  1/09/2014 → 31/08/2015

  Project: Research

• A clinically integrated translational science programme to progress positive biomarker and therapeutics development for forms of breast cancer currently defined as Triple Negative

  Tutt, A. (Primary Investigator), Karagiannis, S. (Co-Investigator), Nestle, F. (Co-Investigator), Ng, T. (Co-Investigator) & Grigoriadis, A. (Co-Investigator)

  Breakthrough Breast Cancer, Breast Cancer Now

  15/10/2013 → 31/10/2022

  Project: Research

• Enhanced prediction of invasive potential of DCIS of the breast (budget for years 1-2 of 3)

  Pinder, S. (Primary Investigator), Brown, J. (Co-Investigator), Grigoriadis, A. (Co-Investigator) & Grigoriadis, A. (Co-Investigator)

  Breast Cancer Research Trust

  1/10/2012 → 30/09/2015

  Project: Research

• Identification of biomarkers that predict tumour progression in lobular carcinoma in situ

  Sawyer, E. (Primary Investigator), Grigoriadis, A. (Co-Investigator), Holmberg, L. (Co-Investigator), Mackay, A. (Co-Investigator), Pinder, S. (Co-Investigator), Roylance, R. (Co-Investigator) & Tomlinson, I. (Co-Investigator)

  1/01/2011 → 31/12/2013

  Project: Research

• Cancer / testis - X antigens involvement in triple negative breast tumourigenesis

  Grigoriadis, A. (Primary Investigator), Hayday, A. (Primary Investigator) & Tutt, A. (Primary Investigator)

  1/10/2010 → 30/09/2013

  Project: Research

• The role of tumour heterogeneity in the establishment of clonality in breast cancer recurrences using array comparative genomic hybridization

  Lüchtenborg, M. (Primary Investigator), Grigoriadis, A. (Co-Investigator), Holmberg, L. (Co-Investigator), Makay, A. (Co-Investigator) & Tutt, A. (Co-Investigator)

  1/04/2010 → 30/09/2010

  Project: Research

• Cancer/testis-X antigens overexpression in basal-like breast cancers due to aberrant activation of the X-chromosome

  Grigoriadis, A. (Primary Investigator), Holmberg, L. (Primary Investigator) & Tutt, A. (Co-Investigator)

  1/01/2010 → 31/12/2012

  Project: Research

• NIHR Biomedical Research Centre

  Afzali, B. (Primary Investigator), Antoniou, M. (Primary Investigator), Barker, J. (Primary Investigator), Barratt, B. (Primary Investigator), Beighton, D. (Primary Investigator), Bevan, S. (Primary Investigator), Blower, P. (Primary Investigator), Burchell, J. (Primary Investigator), Cason, J. (Primary Investigator), Chappell, L. (Primary Investigator), Cope, A. (Primary Investigator), Corrigan, C. (Primary Investigator), Cunninghame Graham, D. (Primary Investigator), Dontu, G. (Primary Investigator), Edgeworth, J. (Primary Investigator), Farzaneh, F. (Primary Investigator), Gee, T. (Primary Investigator), Gould, H. (Primary Investigator), Green, P. (Primary Investigator), Greenough, A. (Primary Investigator), Grigoriadis, A. (Primary Investigator), Hayday, A. (Primary Investigator), Higginson, I. (Primary Investigator), Kalra, L. (Primary Investigator), Karagiannis, S. (Primary Investigator), Kelly, F. (Primary Investigator), Kemper, C. (Primary Investigator), Lau-Walker, M. (Primary Investigator), Lavender, P. (Primary Investigator), Lee, T. (Primary Investigator), Lempp, H. (Primary Investigator), Lewis, C. (Primary Investigator), Lombardi, G. (Primary Investigator), Lord, G. (Primary Investigator), Marber, M. (Primary Investigator), Mason, J. (Primary Investigator), Mathew, C. (Primary Investigator), McGrath, J. (Primary Investigator), Metcalfe, A. (Primary Investigator), Molokhia, M. (Primary Investigator), Mullen, G. (Primary Investigator), Nagel, E. (Primary Investigator), Neil, S. (Primary Investigator), Nestle, F. (Primary Investigator), Oakey, R. (Primary Investigator), Parker, P. (Primary Investigator), Peakman, M. (Primary Investigator), Perera, D. (Primary Investigator), Purushotham, A. (Primary Investigator), Rasekh Ahmadi, K. (Primary Investigator), Rashid, T. (Primary Investigator), Razavi, R. (Primary Investigator), Ridley, A. (Primary Investigator), Robson, M. (Primary Investigator), Sacks, S. (Primary Investigator), Sanchez Fueyo, A. (Primary Investigator), Santis, G. (Primary Investigator), Sanz Moreno, V. (Primary Investigator), Sawyer, E. (Primary Investigator), Schaeffter, T. (Primary Investigator), Shah, A. (Primary Investigator), Sharpe, P. (Primary Investigator), Simpson, M. (Primary Investigator), Smith, R. (Primary Investigator), Sorinola, I. (Primary Investigator), Spector, T. (Primary Investigator), Spicer, J. (Primary Investigator), Taams, L. (Primary Investigator), Tavassoli, M. (Primary Investigator), Taylor, D. (Primary Investigator), Tree, T. (Primary Investigator), Trembath, R. (Primary Investigator), Tribe, R. (Primary Investigator), Tutt, A. (Primary Investigator), Waltham, M. (Primary Investigator), Watt, F. (Primary Investigator), Webb, A. (Primary Investigator), Wells, C. (Primary Investigator), Whelan, K. (Primary Investigator), Whitaker, J. (Primary Investigator), Whittlesea, C. (Primary Investigator), Williamson, C. (Primary Investigator), Wolfe, C. (Primary Investigator), Yu, V. (Primary Investigator), academic, A. (Primary Investigator), Hughes, S. (Co-Investigator), Montana, G. (Co-Investigator), Rhode, K. (Co-Investigator), Schnabel, J. (Co-Investigator) & Tziotzios, C. (Co-Investigator)

  NIHR National Institute For Health & Care Research, DHSC Department of Health and Social Care

  1/04/2007 → 31/03/2017

  Project: Research

  • T-Helper Cell 100%
  • Inflammatory Arthritis 66%
  • Monocyte 36%
  • Tumor Necrosis Factor 36%
  • Cytotoxic T-Cell 33%